#United States #Radnor #class action lawsuit #Kessler Topaz Meltzer & Check #Geron Corporation

Securities Class Action Lawsuit Against Geron Corporation

In a significant development for investors, Kessler Topaz Meltzer & Check, LLP has announced the filing of securities class action lawsuits targeting Geron Corporation (NASDAQ: GERN). This legal action is specifically for those who bought or acquired securities from Geron between February 28, 2024, and February 25, 2025, a period referred to as the 'Class Period.' Investors are encouraged to take action, as the deadline for appointing a lead plaintiff representative of the class is set for May 12, 2025.

Allegations Against Geron Corporation

The primary allegations involve misleading statements and a failure to disclose essential information regarding Geron's business operations and financial outlook. According to the complaints, the defendants purportedly misrepresented Geron's revenue projections and growth potential while downplaying the inherent risks associated with market fluctuations and seasonality.

Specifically, the allegations suggest that:
1. Misleading Growth Expectations: The defendants created a false narrative regarding Geron's anticipated revenue, implying they had reliable data about the company's future prospects, which they allegedly did not possess.
2. Product Launch Misrepresentations: Reports regarding the success of Geron's primary product, RYTELO, were exaggerated. The supposed optimism surrounding the product's launch did not align with the actual market realities, where competition and seasonal effects played a more critical role than implied.
3. Market Awareness Issues: There are claims that RYTELO lacked the necessary market awareness and penetration to meet the purported high demand, particularly among first-line patients and beyond academic settings.
4. Materially False Statements: The defendants’ comments regarding the company’s operations and future prospects are alleged to be materially false and misleading, not based on reasonable analysis throughout the class period.

The Role of Lead Plaintiff

As part of the class action process, affected Geron investors have until May 12, 2025, to seek appointments as a lead plaintiff through Kessler Topaz Meltzer & Check, LLP or other legal counsel. The lead plaintiff is a representative party who acts on behalf of all members of the class in managing the litigation. Typically, this role is filled by the investor or a small group of investors who have sustained the largest financial losses and who embody the profile of the wider affected group.

Those who choose not to serve as lead plaintiffs can still remain members of the class without affecting their rights to recover from any potential settlements.

Next Steps for Investors

Kessler Topaz Meltzer & Check, LLP urges Geron investors who experienced notable losses to directly reach out for more information. The firm specializes in prosecuting class actions and has a distinguished reputation for holding corporations accountable for fraud, taking action to safeguard the interests of investors, and recovering significant sums for those harmed by corporate misconduct.

For more details, investors can visit their website or contact attorney Jonathan Naji directly via phone or email. The full scope of the lawsuit will unfold as the proceedings progress, but already, it represents a potential turning point for Geron Corporation and its stakeholders, emphasizing the importance of corporate transparency and accountability.

For those directly affected by this case, staying informed and actively participating in the legal process will be crucial in navigating the complex world of securities litigation.